To elicit an effective immune response in so-called ‘immune desert tumors’, which are devoid of lymphocyte infiltration, little TMB, and low PD-L1 expression, the main challenge is to attract effector T cells to the TME and present them with the tumor antigens. Here, CD274 is linked to neoplasm.